By integrating data from 67 studies encompassing over 4000 pediatric cases, we evaluated both established biomarkers such as NT-proBNP and troponin, as well as a panel of emerging biomarkers reflecting endothelial dysfunction and immune dysregulation. The gene discussed is NPPB; the disease is endothelial dysfunction.